Latest News

  • INNOVATION

    14 Nov 2025

    Can Tiny Injections Replace Big Infusions
  • TECHNOLOGY

    12 Nov 2025

    AI Redesigns How America Makes Its Medicines
  • PARTNERSHIPS

    11 Nov 2025

    Allies in Innovation: The Rise of Drug Delivery Partnerships
  • RESEARCH

    7 Nov 2025

    Nanoform and Takeda Bet on Miniature Science

The Next Big Breakthrough in Biologics Starts at Home

The Next Big Breakthrough in Biologics Starts at Home

INNOVATION

5 Nov 2025

Halozyme’s Elektrofi buy brings next-gen innovation to biologic drug delivery

The $900M Shot at Reinventing Biologic Delivery

TECHNOLOGY

15 Oct 2025

The $900M Shot at Reinventing Biologic Delivery

Halozyme’s Elektrofi deal could turn complex infusions into quick, patient-friendly injections

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

PARTNERSHIPS

14 Oct 2025

Biologic Breakthrough or Bet? Axio and Likarda Join Forces

New partnership weaves delivery into early biologic design, sparking cautious optimism for future impact

Wearables and Biologics Push Care Beyond the Clinic

INSIGHTS

13 Oct 2025

Wearables and Biologics Push Care Beyond the Clinic

US firms pioneer wearable and greener drug-delivery systems as biologics reshape patient care

A $900 Million Shot: Halozyme Targets Smoother Drug Delivery

RESEARCH

10 Oct 2025

A $900 Million Shot: Halozyme Targets Smoother Drug Delivery

Halozyme’s $900M Elektrofi deal aims to speed up and simplify injectable biologic treatments

Faster Shots for Cancer Care: Merck’s Keytruda Qlex Debuts

INNOVATION

8 Oct 2025

Faster Shots for Cancer Care: Merck’s Keytruda Qlex Debuts

Merck’s subcutaneous Keytruda Qlex offers faster cancer dosing, though IV remains the mainstay for most patients.

Evonik–Ethris Alliance Targets Next Leap in RNA Medicine

INVESTMENT

22 Sep 2025

Evonik–Ethris Alliance Targets Next Leap in RNA Medicine

Alliance aims to improve RNA stability and scaling, with potential to ease storage demands and broaden access

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.